Lu AF20513

DRUG2 trials

Sponsors

H. Lundbeck A/S

Conditions

Alzheimer DiseaseAlzheimer's Disease

Phase 1

A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

TerminatedNCT03668405

H. Lundbeck A/SAlzheimer's Disease

Start: 2018-06-26End: 2019-05-27Updated: 2019-11-21

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

TerminatedNCT03819699

H. Lundbeck A/SAlzheimer Disease

Start: 2018-12-12End: 2019-06-27Updated: 2020-02-21